New hope for Hard-to-Treat cancers: targeted drug E303 enters human trials
Disease control
Recruiting now
This early-stage trial tests a new drug called E303 in people with advanced solid tumors that have not responded to standard treatments. The drug works by targeting a protein called nectin-4 found on many cancer cells. The main goals are to check safety and see if the drug can sh…
Phase: PHASE1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 04:28 UTC